Back to results
US 6,713,053 B1Granted
Use of IL-7 for treating auto-immune diseases and insulin-dependent diabetes mellitus in particular
AssigneeSanofi-Synthelabo
InventorsJean Francois Bach, Jean Marc Gombert, Andre Herbelin, Michel Morre
Life of this patent
Estimating the term…
Abstract
The use of interleukin 7 or T cells pre-incubated in the presence of IL-7 for preparing a drug or pharmaceutical composition for treating an auto-immune disease, particularly an auto-immune disease induced by a defect in CD4+ T cell immunoregulation, is disclosed.
Claims1
A method for the treatment of insulin-dependent diabetes mellitus which comprises administering to a patient in need of such treatment a therapeutically effective amount of interleukin-7.
Dependencies are inferred from the claim text.